stem cell therapy for osteoarthritis (OA) is the most common form of arthritis and affects an estimated 25% of adults in the United States. Characterized by pain, stiffness, and inflammation in the joints of the body, OA is most frequently observed in the knees, hands, hips, and spine. OA is one of the leading causes of…
Mesenchymal stem cells (MSCs) have been widely used in a number of applications designed to aid in the regeneration and healing of human tissue. Prized for their multipotent capacity to differentiate into a variety of other specific cell types, MSCs have consistently demonstrated the ability to seek out damaged tissue while also reducing inflammation and promoting…
Those afflicted with chronic obstructive pulmonary disease (COPD) struggle with persistent respiratory concerns stemming from airflow blockage and lung inflammation. Here we will discuss regenerative Medicine for COPD. The conditions that contribute to COPD, such as emphysema and chronic bronchitis, can cause excess mucus production, frequent coughing, wheezing, or shortness of breath. While treatments including lifestyle…
Currently, it’s estimated that nearly 1.5 million Americans are living with type 1 diabetes (T1D), a number that is expected to increase to over 2 million by the year 2040[1]. In the U.S. alone, healthcare costs and lost wages directly related to T1D currently exceed $16 billion per year. While the most common treatment…
Mesenchymal stem cells (MSCs) have demonstrated the ability to differentiate into a number of different cells; they also demonstrate immunomodulatory properties that have great potential for use as a stem cell-based therapeutic treatment option and for the treatment of stem cell therapy for autoimmune conditionss - including rheumatoid arthritis (RA). RA is a chronic and…
The number of people experiencing autoimmune diseases (ADs) continues to increase worldwide. Currently, it's estimated that between 2 and 5% of the global population is afflicted with the most severe forms of these diseases, including type 1 diabetes (T1DM), systemic lupus erythematosus (SLE), and regenerative medicine for rheumatoid arthritis (RA). An stem cell therapy for…
Stem cells are essential in understanding human development, disease, injury, and potential treatments and cures. However, since the initial research on these critical cells began with embryonic stem cells, many people dismiss the benefits of stem cell research and treatment as controversial. Unfortunately, that dismissal ignores what may be of adult stem cells, which are more…
Spinal cord injury (SCI) continues to be a significant cause of disability. In fact, it is estimated that annual SCIs account for nearly 18,000 injuries in the United States and between 250,000 and 500,000 injuries worldwide[1]. While the main cause of SCIs in the United States continues to be motor vehicle accidents, other contributors include…
Stem cells, and specifically mesenchymal stem cells (MSCs), have long been considered as a promising therapeutic agent for the treatment of a wide variety of degenerative and ischemic diseases. Over this time, MSC immunomodulation, their capacity for multilineage differentiation, and their ability to self-renew have been well established and are now considered to be clinically…
Osteoarthritis (OA) is the most common form of arthritis, affecting over 525 million people around the world. Characterized by pain, swelling, and stiffness resulting from the degradation of cartilage that provides cushion and protection between our bones, OA is an inflammatory condition without a clear and effective treatment. OA most commonly affects the hands, knees,…
We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!